Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...

TAVR (Transcatheter Aortic Valve Replacement) is a minimally invasive heart procedure that replaces a narrowed aortic valve ...

Dr. Vijay S. Iyer, MD, Ph.D., FACC, is a distinguished interventional cardiologist specializing in complex cardiac and ...

EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.

It’s Heart Health Month and we’re discussing what you need to know about a potentially lifesaving approach to treat a heart ...

The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its ...

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Aortic stenosis is fairly uncommon among young people, though not absent. In younger folks, the disease is typically caused by a congenital heart condition. As we age, calcium deposits can build up ...